# TELA Bio to Announce First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/TELA/tela-bio-to-announce-first-quarter-2026-financial-results
Ticker: TELA
Company: TELA Bio
Source: TELA Bio
Published: 2026-04-21 20:05 EST
Original Source URL: https://ir.telabio.com
## Summary

MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2026 financial results on

## Article Body
MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2026 financial results on
## Recent Company News
- 2026-05-12 20:05 EST — [TELA Bio Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TELA/tela-bio-reports-first-quarter-2026-financial-results) — Source: TELA Bio
- 2026-04-30 20:43 EST — [TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues](https://biopharmsignal.com/news/TELA/tela-bio-announces-strategic-board-refreshment-with-four-highly-experienced-commerical-leaders-to-accelerate-growth-and-drive-path-to-profitability-the-company-also-reports-preliminary-first-quarter-2026-revenues) — Source: TELA Bio
- 2026-04-21 20:05 EST — [TELA Bio to Announce First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TELA/tela-bio-to-announce-first-quarter-2026-financial-results) — Source: TELA Bio
- 2026-03-24 20:05 EST — [TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results](https://biopharmsignal.com/news/TELA/tela-bio-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: TELA Bio
- 2026-03-10 20:05 EST — [TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results](https://biopharmsignal.com/news/TELA/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results) — Source: TELA Bio
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)